Literature DB >> 35596847

Pregnant and Postpartum People with Substance Use Disorders: Understanding the Obstetrical Care Provider' s Roles and Responsibilities.

Marlee Madora1, Scott Wetzler2, Anita Jose2, Peter S Bernstein3.   

Abstract

Peripartum individuals with substance misuse are a high-risk population that challenge clinicians and child welfare specialists alike. Federal legislation was updated in 2016 with the Comprehensive Addiction Recovery Act (CARA) to improve care via expanded screening and treatment referrals for peripartum women with substance misuse. The implementation of CARA requires providers to update their policies and procedures in order to meet the requirements outlined by this legislation. As this is a new process, this paper reviews the new administrative reporting and safety planning requirements relevant to obstetrical care providers and provides examples of best practice for different clinical scenarios. Given the variable state laws, confidentiality concerns, influence of stigma and health inequities on substance use treatment, and the fragmented healthcare system, implementation of CARA will challenge obstetric, pediatric, and mental health care providers along with child welfare services. All entities involved must work together to create effective and efficient protocols to address the CARA requirements. Health systems must also evaluate and update methods and interventions to assure that policies improve family stability and well-being.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Child welfare; Comprehensive Addiction Recovery Act; Maternal substance use; Obstetrics; Plan of Safe Care

Mesh:

Year:  2022        PMID: 35596847     DOI: 10.1007/s10995-022-03446-x

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  8 in total

1.  Medical specialization, profession, and mediating beliefs that predict stated likelihood of alcohol screening and brief intervention: targeting educational interventions.

Authors:  Ruth A Gassman
Journal:  Subst Abus       Date:  2003-09       Impact factor: 3.716

Review 2.  Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.

Authors:  Jennifer B Saunders; Marian P Jarlenski; Robert Levy; Katy B Kozhimannil
Journal:  Womens Health Issues       Date:  2017-11-26

Review 3.  Epidemiology of perinatal substance use: Exploring trends in maternal substance use.

Authors:  Jennifer J Rodriguez; Vincent C Smith
Journal:  Semin Fetal Neonatal Med       Date:  2019-02-06       Impact factor: 3.926

4.  Treatment for substance use disorders in pregnant women: Motivators and barriers.

Authors:  Zane Frazer; Krystle McConnell; Lauren M Jansson
Journal:  Drug Alcohol Depend       Date:  2019-10-22       Impact factor: 4.492

5.  The effect of race on provider decisions to test for illicit drug use in the peripartum setting.

Authors:  Hillary Veda Kunins; Eran Bellin; Cynthia Chazotte; Evelyn Du; Julia Hope Arnsten
Journal:  J Womens Health (Larchmt)       Date:  2007-03       Impact factor: 2.681

6.  Patients' characteristics and providers' attitudes: predictors of screening pregnant women for illicit substance use.

Authors:  Bonnie D Kerker; Sarah M Horwitz; John M Leventhal
Journal:  Child Abuse Negl       Date:  2004-02

7.  Arrests of and forced interventions on pregnant women in the United States, 1973-2005: implications for women's legal status and public health.

Authors:  Lynn M Paltrow; Jeanne Flavin
Journal:  J Health Polit Policy Law       Date:  2013-01-15       Impact factor: 2.265

8.  How does family drug treatment court participation affect child welfare outcomes?

Authors:  Elizabeth Joanne Gifford; Lindsey Morgan Eldred; Allison Vernerey; Frank Allen Sloan
Journal:  Child Abuse Negl       Date:  2014-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.